.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Updates in SCLC: Advances in Treatment

Drs Carl M. Gay and Jared Weiss highlight novel treatment advances for newly diagnosed and relapsed/refractory small cell lung cancer.

EP. 1: Criteria Used to Diagnose Small Cell Lung Cancer

January 31st 2022

Symptoms and risk factors associated with small cell lung cancer, and recommendations for staging patients with newly diagnosed disease.

EP. 2: Small Cell Lung Cancer: Frontline Treatment Decisions

February 7th 2022

Current considerations that affect the choice of frontline therapy for patients with small cell lung cancer with the availability of novel systemic therapies.

EP. 3: Treatment Options for Relapsed Small Cell Lung Cancer

February 14th 2022

Available treatment options as second-line therapy for small cell lung cancer.

EP. 4: SCLC: Future Therapies and Advice to Community Oncologists

February 21st 2022

Drs Carl M. Gay and Jared Weiss highlight several novel strategies that show promise in optimizing treatment for patients with small cell lung cancer and respond to questions from community oncologists who manage treatment for patients with lung cancer.